SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-22-000053
Filing Date
2022-03-22
Accepted
2022-03-22 08:00:28
Documents
13
Period of Report
2022-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K selb-20220321.htm   iXBRL 8-K 41451
2 EX-10.1 exhibit101_secondamendment.htm EX-10.1 37590
  Complete submission text file 0001453687-22-000053.txt   224025

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT selb-20220321.xsd EX-101.SCH 1946
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT selb-20220321_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT selb-20220321_pre.xml EX-101.PRE 12548
7 EXTRACTED XBRL INSTANCE DOCUMENT selb-20220321_htm.xml XML 10821
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 22757209
SIC: 2834 Pharmaceutical Preparations